Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Changes in Gut Microbiota in Patients with Multiple Sclerosis Based on 16s rRNA Gene Sequencing Technology: A Review and Meta-Analysis

9 Jul 2024

Abstract excerpt

Background: This meta-analysis explores alterations in the gut microbiota of patients with Multiple Sclerosis (MS) using 16S ribosomal RNA (rRNA) gene sequencing. Methods: Adhering to Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, our comprehensive review spanned major databases, including PubMed, Web of Science, Embase, Cochrane, and Ovid, targeting observational studies...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clostridium difficile and Clostridium perfringens research
Share to Gut microbiota and health
Share to Multiple Sclerosis Research Studies

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39082295
DOI: 10.31083/j.jin2307127

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Changes in Gut Microbiota in Patients with Multiple Sclerosis Based on 16s rRNA Gene Sequencing Technology: A Review and Meta-AnalysisPMID 39082295Read ↗

Meta-analysis identifies common gut microbiota associated with multiple sclerosisSemantic proximity Read ↗

Meta-analysis identifies common gut microbiota signatures in patients with multiple sclerosisSemantic proximity Read ↗

Gut microbiome variation is associated to Multiple Sclerosis phenotypic subtypes.Semantic proximity Read ↗

Microbiota-Driven Mechanisms in Multiple Sclerosis: Pathogenesis, Therapeutic Strategies, and Biomarker PotentialSemantic proximity Read ↗

The gut microbiota in multiple sclerosis varies with disease activitySemantic proximity Read ↗

Multiple sclerosis patients have a distinct gut microbiota compared to healthy controlsSemantic proximity Read ↗

Alterations of the human gut microbiome in multiple sclerosisSemantic proximity Read ↗

Identification of commensal gut microbiota signatures as predictors of clinical severity and disease progression in multiple sclerosisSemantic proximity Read ↗

Identification of commensal gut microbiota signatures as predictors of clinical severity and disease progression in multiple sclerosisSemantic proximity Read ↗

The Role of the Gut Microbiome in Multiple Sclerosis Risk and Progression: Towards Characterization of the “MS Microbiome”Semantic proximity Read ↗

B-Cell-Depletion Reverses Dysbiosis of the Microbiome in Multiple Sclerosis PatientsSemantic proximity Read ↗

Specific microbial ratio in the gut microbiome is associated with multiple sclerosisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.